{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:50:29Z","timestamp":1790027429472,"version":"4.0.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA21765"],"award-info":[{"award-number":["CA21765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA36401-26S1"],"award-info":[{"award-number":["CA36401-26S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM92666"],"award-info":[{"award-number":["GM92666"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,13]]},"DOI":"10.1093\/cid\/cix644","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T03:10:56Z","timestamp":1500952256000},"page":"1790-1798","source":"Crossref","is-referenced-by-count":84,"title":["Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia"],"prefix":"10.1093","volume":"65","author":[{"given":"Joshua","family":"Wolf","sequence":"first","affiliation":[{"name":"Departments of 1Infectious Diseases"},{"name":"Department of Pediatrics, University of Tennessee Health Science Center, Memphis"},{"name":"Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[{"name":"Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M","family":"Flynn","sequence":"additional","affiliation":[{"name":"Departments of 1Infectious Diseases"},{"name":"Department of Pediatrics, University of Tennessee Health Science Center, Memphis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Tennessee Health Science Center, Memphis"},{"name":"Oncology"},{"name":"Pathology, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya H","family":"Gaur","sequence":"additional","affiliation":[{"name":"Departments of 1Infectious Diseases"},{"name":"Department of Pediatrics, University of Tennessee Health Science Center, Memphis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilun","family":"Sun","sequence":"additional","affiliation":[{"name":"Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Tennessee Health Science Center, Memphis"},{"name":"Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Stewart","sequence":"additional","affiliation":[{"name":"Departments of 1Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall T","family":"Hayden","sequence":"additional","affiliation":[{"name":"Pathology, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Hakim","sequence":"additional","affiliation":[{"name":"Departments of 1Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Jeha","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Tennessee Health Science Center, Memphis"},{"name":"Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"key":"key\n\t\t\t\t20180306232459_CIT0001","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2141.2005.05736.x","article-title":"Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992\u20132001","volume":"131","author":"Christensen","year":"2005","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180306232459_CIT0002","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/annonc\/mdw557","article-title":"Infection-related complications during treatment for childhood acute lymphoblastic leukemia","volume":"28","author":"Inaba","year":"2017","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180306232459_CIT0003","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2014-03-560847","article-title":"Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003","volume":"124","author":"O\u2019Connor","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180306232459_CIT0004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.leu.2403665","article-title":"Causes of death\u2013other than progressive leukemia\u2013in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience","volume":"19","author":"Slats","year":"2005","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180306232459_CIT0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.PCC.0000165560.90814.59","article-title":"Outcome of severe sepsis in pediatric oncology patients","volume":"6","author":"Fiser","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"key\n\t\t\t\t20180306232459_CIT0006","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180306232459_CIT0007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nature13828","article-title":"Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile","volume":"517","author":"Buffie","year":"2015","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180306232459_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cit155","article-title":"Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children","volume":"57","author":"Sammons","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306232459_CIT0009","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pbc.20065","article-title":"A pilot study of prophylactic ciprofloxacin during delayed intensification in children with acute lymphoblastic leukemia","volume":"43","author":"Yousef","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"key\n\t\t\t\t20180306232459_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JBM.S33906","article-title":"Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia","volume":"4","author":"Widjajanto","year":"2013","journal-title":"J Blood Med"},{"key":"key\n\t\t\t\t20180306232459_CIT0011","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180306232459_CIT0012","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306232459_CIT0013","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1200\/JCO.2012.42.7161","article-title":"Guideline for the management of fever and neutropenia in children with cancer and\/or undergoing hematopoietic stem-cell transplantation","volume":"30","author":"Lehrnbecher","year":"2012","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180306232459_CIT0014","author":"National Cancer Institute","year":"2006"},{"key":"key\n\t\t\t\t20180306232459_CIT0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pbc.25335","article-title":"Core outcomes and definitions for pediatric fever and neutropenia research: a consensus statement from an international panel","volume":"62","author":"Haeusler","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"key\n\t\t\t\t20180306232459_CIT0016","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2001.19.14.3415","article-title":"Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever","volume":"19","author":"Santolaya","year":"2001","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180306232459_CIT0017","author":"Centers for Disease Control and Prevention"},{"key":"key\n\t\t\t\t20180306232459_CIT0018","author":"Centers for Disease Control and Prevention"},{"key":"key\n\t\t\t\t20180306232459_CIT0019","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"key\n\t\t\t\t20180306232459_CIT0020","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/sim.1047","article-title":"A solution to the problem of separation in logistic regression","volume":"21","author":"Heinze","year":"2002","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20180306232459_CIT0021","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01646878","article-title":"Prophylactic co-trimoxazole versus norfloxacin in neutropenic children\u2013perspective randomized study","volume":"17","author":"Cruciani","year":"1989","journal-title":"Infection"},{"key":"key\n\t\t\t\t20180306232459_CIT0022","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/INF.0b013e3182793610","article-title":"Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy","volume":"32","author":"Laoprasopwattana","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180306232459_CIT0023","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood.V126.23.249.249","article-title":"Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia","volume":"126","author":"Sulis","year":"2015","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180306232459_CIT0024","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/cncr.28524","article-title":"Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis","volume":"120","author":"Yeh","year":"2014","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180306232459_CIT0025","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/INF.0000000000000591","article-title":"Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia","volume":"34","author":"Felsenstein","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180306232459_CIT0026","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/pbc.22423","article-title":"Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis","volume":"55","author":"Rungoe","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"key\n\t\t\t\t20180306232459_CIT0027","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jpids\/pis034","article-title":"Healthcare-associated infections at a children\u2019s cancer hospital, 1983\u20132008","volume":"1","author":"McCullers","year":"2012","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key\n\t\t\t\t20180306232459_CIT0028","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/j.seminhematol.2013.06.007","article-title":"A 50-year journey to cure childhood acute lymphoblastic leukemia","volume":"50","author":"Pui","year":"2013","journal-title":"Semin Hematol"},{"key":"key\n\t\t\t\t20180306232459_CIT0029","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MPH.0000000000000417","article-title":"Fever at diagnosis of pediatric acute lymphoblastic leukemia: are antibiotics really necessary?","volume":"37","author":"Khurana","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"key\n\t\t\t\t20180306232459_CIT0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jpids\/piu008","article-title":"Variation in risk of hospital-onset Clostridium difficile infection across \u03b2-lactam antibiotics in children with new-onset acute lymphoblastic leukemia","volume":"3","author":"Fisher","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key\n\t\t\t\t20180306232459_CIT0031","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/INF.0b013e31820bfb29","article-title":"Epidemiology and risk factors for Clostridium difficile infection in children","volume":"30","author":"Sandora","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180306232459_CIT0032","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"Stevens","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306232459_CIT0033","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/INF.0b013e31820970d1","article-title":"Clostridium difficile infection among children with cancer","volume":"30","author":"Tai","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180306232459_CIT0034","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jpeds.2013.01.062","article-title":"Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer","volume":"163","author":"de Blank","year":"2013","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20180306232459_CIT0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","article-title":"Effects of control interventions on Clostridium difficile infection in England: an observational study","volume":"17","author":"Dingle","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180306232459_CIT0036","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1182\/blood-2013-01-476614","article-title":"Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children\u2019s Oncology Group","volume":"121","author":"Sung","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180306232459_CIT0037","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3109\/10428194.2012.736988","article-title":"Fluoroquinolone prophylaxis: worth the cost?","volume":"54","author":"Haeusler","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180306232459_CIT0038","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10096-005-1278-x","article-title":"Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia","volume":"24","author":"Kern","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180306232459_CIT0039","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/tid.12298","article-title":"Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period","volume":"16","author":"Macesic","year":"2014","journal-title":"Transpl Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/65\/11\/1790\/24266886\/cix644.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T12:24:36Z","timestamp":1659270276000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/65\/11\/1790\/4157396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,9,14]]},"published-print":{"date-parts":[[2017,11,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix644","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,1]]},"published":{"date-parts":[[2017,9,14]]}}}